Cargando…
As the virus evolves, so too must we: a drug developer’s perspective: We need a new paradigm in searching for next-generation countermeasures
The SARS-CoV-2 virus has been raging globally for over 2 years with no end in sight. It has become clear that this virus possesses enormous genetic plasticity, and it will not be eradicated. Under increasing selective pressure from population immunity, the evolution of SARS-CoV-2 has driven it towar...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549815/ https://www.ncbi.nlm.nih.gov/pubmed/36217145 http://dx.doi.org/10.1186/s12985-022-01887-y |